# Oil Frenzy: Bulls Charge, Markets Flip! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-04-06T14:00:00.207Z Source: https://newsyai.com/edition/76cd94b8-500a-414a-bc56-f3607a700678 Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- # Oil Flip-Flops at $112 Frenzy: Buyout Bulls Charge, Space Degens Dream, Pivot Punks Pivot! **Premarket piss-fight rages**—**Dow futures ~46,629 -0.22%**[[1]](https://www.cnn.com/markets/premarkets)[[2]](https://www.tradingview.com/symbols/CBOT_MINI-YM1!), **S&P -0.28% ~6,603**[[1]](https://www.cnn.com/markets/premarkets)[[3]](https://finance.yahoo.com/quote/ES=F), **Nasdaq -0.36% ~24,129**[[1]](https://www.cnn.com/markets/premarkets) as WTI crude **yo-yos from $115 high to $112** on Iran jitters easing whispers and OPEC+ tease![[28]](https://www.cnbc.com/quotes/@CL.1)[[30]](https://www.marketwatch.com/investing/future/cl.1) **SLNO** buyout blast-off +7%+, **SPCE** space-ticket spike +11%, **UGRO** cricket curveball +11%—analysts arm-wrestling amid oil orgasm fade![[47]](https://www.cnn.com/markets/premarkets)[[50]](https://www.tradingview.com/markets/stocks-usa/market-movers-pre-market-gainers) --- ## 1) Soleno Therapeutics (SLNO): “$2.9B Neurocrine Nuptials Nirvana” vs “Buyout Bait-and-Switch Bust” **Why it’s loud** **SLNO** rocketing **+7%+ to ~$40** premarket vol nuclear—Neurocrine inks **$53/share cash deal ($2.9B EV, 34% premium)** for rare disease pipeline![[79]](https://seekingalpha.com/news/4572623-neurocrine-to-buy-soleno-therapeutics-for-53share-in-cash)[[81]](https://www.prnewswire.com/news-releases/neurocrine-to-acquire-soleno-therapeutics-expanding-its-endocrinology-and-rare-disease-portfolio-302734531.html) **Bull case (acquisition ass-kicker)** DCCR for Prader-Willi syndrome Phase 3 win primed—$1B+ peak sales, Neurocrine’s rare disease muscle accelerates approval; premium screams value![[75]](https://finance.yahoo.com/quote/SLNO) **Bear case (deal diarrhea probe party)** Law firm sniffing "fairness," biotech M&A morgue full of corpses—integration indigestion or regulatory rug-pull torches spread![[83]](https://www.rutlandherald.com/news/business/slno-stock-alert-halper-sadeh-llc-is-investigating-whether-soleno-therapeutics-inc-is-obtaining-a/article_a89db860-640b-5505-bc68-61775771f7ed.html) **My take, first principles (small mol metabolic magic vs merger meat-grinder)** Bio: Diazoxide choline restores K-ATP channels for hyperphagia control—gold-standard unmet need, 90-day close likely but antitrust sniff-test looms. **Raid $38-41**, **$50/$55 calls** wedding walk—**puts $35** if probe puke. Risk: FTC fuckery.[[77]](https://investors.soleno.life/stock-information/stock-quote-chart) --- ## 2) Virgin Galactic (SPCE): “$750K Ticket Sales Space Boner” vs “Cash-Burn Black Hole Bullshit” **Why it’s loud** **SPCE** blasting **+11% to $2.74** premarket—reopens **$750K Delta-class tickets**, management shakeup signals commercial cock-up soon![[50]](https://www.tradingview.com/markets/stocks-usa/market-movers-pre-market-gainers)[[90]](https://www.reddit.com/r/VirginGalactic) **Bull case (suborbital slut strut)** 2026 flights ramp: 125 missions/year, $450M rev rocket—Branson’s balls-back, backlog bulges![[84]](https://finance.yahoo.com/quote/SPCE) **Bear case (perpetual promise-pumper)** $1B+ cumulative losses, PT slashed to $2.05—Morgan Stanley “no thanks,” endless delays = dilution dick-pic parade![[85]](https://www.cnbc.com/quotes/SPCE) **My take, first principles (airframe reusability vs orbital overpromise)** Aero: Glide-back reduces opex 50x vs rockets, but G-force tourist tolerance unproven—tickets = PR placebo till revenue. **Grab $2.60-2.80**, **$3.50/$4 calls** liftoff—**puts $2.20** vaporware. Risk: FAA fart.[[87]](https://investors.virgingalactic.com/news/default.aspx) --- ## 3) urban-gro (UGRO): “Nasdaq Cricket Pivot Power Surge” vs “Agrotech Abandonment Anal Fumble” **Why it’s loud** **UGRO** jumping **+11% to $21+**—regains Nasdaq compliance, dives into **global T20 cricket media** via Flash merger vibes![[50]](https://www.tradingview.com/markets/stocks-usa/market-movers-pre-market-gainers)[[119]](https://www.tipranks.com/news/company-announcements/urban-gro-unveils-strategic-shift-into-global-cricket-media) **Bull case (hydro-to-highlights homerun)** $1B+ cricket rights TAM, compliance cures delist dread—synergies supercharge recurring rev![[115]](https://www.stocktitan.net/news/UGRO) **Bear case (pivot prostate exam)** Core CEA tech cash-bleeder, cricket curveball = execution erectile dysfunction, dilution deluge likely![[117]](https://public.com/stocks/ugro) **My take, first principles (controlled env ag vs media moonshot madness)** Biz: Pivot taps $50B sports streaming, but IP dilution kills—Nasdaq lifeline buys pivot probation. **Dip-hunt $20-21.50**, **$25/$28 calls** sixer smash—**puts $18** strikeout. Risk: Rev-split roulette.[[113]](https://finance.yahoo.com/quote/UGRO) --- ## Tape-Side Tactics (Oil Whiplash or Acquisition Avalanche?) - **SLNO**: **$38-41** premium play; **$50C/$55C** deal done, **P$35** probe panic.[[81]](https://www.prnewswire.com/news-releases/neurocrine-to-acquire-soleno-therapeutics-expanding-its-endocrinology-and-rare-disease-portfolio-302734531.html) - **SPCE**: **$2.60-2.80** ticket tease; **$3.50C/$4C**, **P$2.20** Branson bust.[[84]](https://finance.yahoo.com/quote/SPCE) - **UGRO**: **$20-21.50** pivot probe; **$25C/$28C**, **P$18** compliance crapshoot.[[115]](https://www.stocktitan.net/news/UGRO) Iran itch or buyout bitch? Load the launches, dump the duds! DYOR, balls to the wall!